ROBOTIC VERSUS OPEN RADICAL CYSTECTOMY: PROSPECTIVE COMPARISON OF PERIOPERATIVE OUTCOMES AND PATHOLOGIC MEASURES OF EARLY ONCOLOGIC EFFICACY
Gerald Wang(NewYork–Presbyterian Hospital), Douglas S. Scherr(Cornell University), Philip S. Li(Cornell University), Daniel A. Barocas(Vanderbilt University Medical Center), Casey K. Ng(NewYork–Presbyterian Hospital), Jay D. Raman(Penn State Milton S. Hershey Medical Center)
Cited by 6
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
|The Journal of Urology|2022|462
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386